← Back to headlines
Rhythm Pharmaceuticals Price Target Lowered by H.C. Wainwright
H.C. Wainwright has lowered its price target for Rhythm Pharmaceuticals to $110 from $125.
3 Mar, 13:24 — 3 Mar, 13:24
Sources
Showing 1 of 1 sources
Related Stories
ECB and Nationalbank Raise Interest Rates to Combat Persistent Inflation
1h ago
Bond Investors Remain Skeptical Despite Bessent's Treasury Buyback
2h ago
Polymarket hires Warren Jenson as its first chief financial officer
2h ago
Macy's Beats Q2 Estimates, Raises Full-Year Outlook as Turnaround Gains Traction
3h ago